CN101302528B - 参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 - Google Patents
参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 Download PDFInfo
- Publication number
- CN101302528B CN101302528B CN2008100823963A CN200810082396A CN101302528B CN 101302528 B CN101302528 B CN 101302528B CN 2008100823963 A CN2008100823963 A CN 2008100823963A CN 200810082396 A CN200810082396 A CN 200810082396A CN 101302528 B CN101302528 B CN 101302528B
- Authority
- CN
- China
- Prior art keywords
- gene
- sequence
- spiramycin
- protein
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004187 Spiramycin Substances 0.000 title claims abstract description 259
- 229930191512 spiramycin Natural products 0.000 title claims abstract description 257
- 235000019372 spiramycin Nutrition 0.000 title claims abstract description 257
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 127
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 119
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 118
- 230000015572 biosynthetic process Effects 0.000 title abstract description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 title description 15
- ACTOXUHEUCPTEW-UHFFFAOYSA-N spiramycins Chemical class CC1CC(CC=O)C(OC2C(C(C(OC3OC(C)C(O)C(C)(O)C3)C(C)O2)N(C)C)O)C(OC)C(O)CC(=O)OC(C)CC=CC=CC1OC1CCC(N(C)C)C(C)O1 ACTOXUHEUCPTEW-UHFFFAOYSA-N 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 902
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 claims abstract description 301
- 229960001294 spiramycin Drugs 0.000 claims abstract description 258
- 238000000034 method Methods 0.000 claims abstract description 73
- 230000014509 gene expression Effects 0.000 claims abstract description 58
- 230000001580 bacterial effect Effects 0.000 claims description 260
- 239000013612 plasmid Substances 0.000 claims description 237
- 241001655322 Streptomycetales Species 0.000 claims description 192
- 230000003570 biosynthesizing effect Effects 0.000 claims description 92
- 239000002157 polynucleotide Substances 0.000 claims description 89
- 108091033319 polynucleotide Proteins 0.000 claims description 87
- 102000040430 polynucleotide Human genes 0.000 claims description 87
- 241000894006 Bacteria Species 0.000 claims description 76
- 239000004927 clay Substances 0.000 claims description 71
- 230000001851 biosynthetic effect Effects 0.000 claims description 57
- 210000004027 cell Anatomy 0.000 claims description 55
- 230000000694 effects Effects 0.000 claims description 55
- 239000002773 nucleotide Substances 0.000 claims description 49
- 241000187747 Streptomyces Species 0.000 claims description 48
- 125000003729 nucleotide group Chemical group 0.000 claims description 48
- 230000002018 overexpression Effects 0.000 claims description 46
- 108020004511 Recombinant DNA Proteins 0.000 claims description 43
- 239000013604 expression vector Substances 0.000 claims description 39
- 230000000813 microbial effect Effects 0.000 claims description 38
- 230000002068 genetic effect Effects 0.000 claims description 37
- 239000000284 extract Substances 0.000 claims description 36
- 150000007523 nucleic acids Chemical class 0.000 claims description 32
- 102000039446 nucleic acids Human genes 0.000 claims description 30
- 108020004707 nucleic acids Proteins 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 29
- -1 fosmids Substances 0.000 claims description 23
- 230000036983 biotransformation Effects 0.000 claims description 14
- 230000000295 complement effect Effects 0.000 claims description 14
- 230000008676 import Effects 0.000 claims description 12
- 241000588724 Escherichia coli Species 0.000 claims description 11
- 239000013598 vector Substances 0.000 claims description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 7
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 7
- 210000004962 mammalian cell Anatomy 0.000 claims description 6
- 239000013605 shuttle vector Substances 0.000 claims description 6
- 210000005253 yeast cell Anatomy 0.000 claims description 6
- 241000238631 Hexapoda Species 0.000 claims description 5
- 241000701447 unidentified baculovirus Species 0.000 claims description 5
- 239000000969 carrier Substances 0.000 claims description 3
- 230000009465 prokaryotic expression Effects 0.000 claims description 3
- 238000001890 transfection Methods 0.000 claims description 3
- 125000000539 amino acid group Chemical group 0.000 claims description 2
- ACTOXUHEUCPTEW-ZOTSFZJCSA-N spiramycin I Natural products CO[C@H]1[C@H](O)CC(=O)O[C@H](C)CC=CC=C[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C ACTOXUHEUCPTEW-ZOTSFZJCSA-N 0.000 abstract description 45
- 229950001955 spiramycin i Drugs 0.000 abstract description 45
- ZPCCSZFPOXBNDL-LWXQEXJOSA-N Spiramycin-II Natural products CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C)OC(=O)C ZPCCSZFPOXBNDL-LWXQEXJOSA-N 0.000 abstract description 31
- ZPCCSZFPOXBNDL-RSMXASMKSA-N spiramycin II Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]([C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)OC(C)=O)[C@H]1CC[C@H](N(C)C)[C@H](C)O1 ZPCCSZFPOXBNDL-RSMXASMKSA-N 0.000 abstract description 31
- 229950006796 spiramycin ii Drugs 0.000 abstract description 31
- HSZLKTCKAYXVBX-VPIGJTHDSA-N Spiramycin-III Natural products CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C)[C@H]1OC HSZLKTCKAYXVBX-VPIGJTHDSA-N 0.000 abstract description 28
- DDQFXRYVNIPXRQ-UHFFFAOYSA-L cyclopenta-1,3-diene;dichlorozirconium(2+);1,2,3,5,5-pentamethylcyclopenta-1,3-diene Chemical compound Cl[Zr+2]Cl.C1C=CC=[C-]1.CC1=[C-]C(C)(C)C(C)=C1C DDQFXRYVNIPXRQ-UHFFFAOYSA-L 0.000 abstract description 28
- 229950003659 spiramycin iii Drugs 0.000 abstract description 28
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 239000000203 mixture Substances 0.000 abstract description 14
- 244000005700 microbiome Species 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 7
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 229940088710 antibiotic agent Drugs 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 238000002955 isolation Methods 0.000 abstract 1
- 239000004576 sand Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 246
- 235000018102 proteins Nutrition 0.000 description 243
- 230000002779 inactivation Effects 0.000 description 94
- 238000003752 polymerase chain reaction Methods 0.000 description 78
- 239000012634 fragment Substances 0.000 description 77
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 69
- 238000009396 hybridization Methods 0.000 description 62
- 239000000523 sample Substances 0.000 description 62
- 102000004190 Enzymes Human genes 0.000 description 60
- 108090000790 Enzymes Proteins 0.000 description 60
- 101100165660 Alternaria brassicicola bsc6 gene Proteins 0.000 description 58
- 101100512049 Arabidopsis thaliana LWD2 gene Proteins 0.000 description 58
- 101100499295 Bacillus subtilis (strain 168) disA gene Proteins 0.000 description 58
- 101150007210 ORF6 gene Proteins 0.000 description 58
- 101100226894 Phomopsis amygdali PaGT gene Proteins 0.000 description 58
- 101100226885 Phomopsis amygdali PaP450-4 gene Proteins 0.000 description 58
- 101100350254 Streptomyces antibioticus oleV gene Proteins 0.000 description 58
- 239000000047 product Substances 0.000 description 54
- 101150073872 ORF3 gene Proteins 0.000 description 53
- 238000003780 insertion Methods 0.000 description 53
- 230000037431 insertion Effects 0.000 description 53
- 239000003120 macrolide antibiotic agent Substances 0.000 description 52
- 230000006870 function Effects 0.000 description 50
- 238000012217 deletion Methods 0.000 description 49
- 230000037430 deletion Effects 0.000 description 49
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 47
- 229950006334 apramycin Drugs 0.000 description 47
- 238000005516 engineering process Methods 0.000 description 40
- 101100437895 Alternaria brassicicola bsc3 gene Proteins 0.000 description 39
- 101100165663 Alternaria brassicicola bsc8 gene Proteins 0.000 description 39
- 101100226896 Phomopsis amygdali PaMT gene Proteins 0.000 description 39
- 101100226891 Phomopsis amygdali PaP450-1 gene Proteins 0.000 description 39
- 108020004414 DNA Proteins 0.000 description 36
- 230000029087 digestion Effects 0.000 description 35
- 231100000350 mutagenesis Toxicity 0.000 description 34
- 101100226887 Phomopsis amygdali PaP450-5 gene Proteins 0.000 description 33
- 238000002703 mutagenesis Methods 0.000 description 33
- 230000032696 parturition Effects 0.000 description 33
- 101100165658 Alternaria brassicicola bsc5 gene Proteins 0.000 description 32
- 101100032924 Bacillus subtilis (strain 168) radA gene Proteins 0.000 description 32
- 101100492392 Didymella fabae pksAC gene Proteins 0.000 description 32
- 101100226893 Phomopsis amygdali PaP450-2 gene Proteins 0.000 description 32
- 108091034117 Oligonucleotide Proteins 0.000 description 28
- 230000003115 biocidal effect Effects 0.000 description 25
- 230000000968 intestinal effect Effects 0.000 description 25
- 238000012882 sequential analysis Methods 0.000 description 25
- 101150071716 PCSK1 gene Proteins 0.000 description 24
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 23
- 101100038645 Streptomyces griseus rppA gene Proteins 0.000 description 21
- 238000013467 fragmentation Methods 0.000 description 21
- 238000006062 fragmentation reaction Methods 0.000 description 21
- 238000004128 high performance liquid chromatography Methods 0.000 description 21
- JYAQWANEOPJVEY-LYFYHCNISA-N mycarose Chemical group C[C@H](O)[C@H](O)[C@](C)(O)CC=O JYAQWANEOPJVEY-LYFYHCNISA-N 0.000 description 21
- 108020004705 Codon Proteins 0.000 description 20
- 101100111747 Eupenicillium brefeldianum Bref-PKS gene Proteins 0.000 description 20
- YQLFLCVNXSPEKQ-UHFFFAOYSA-N Mycarose Natural products CC1OC(O)CC(C)(O)C1O YQLFLCVNXSPEKQ-UHFFFAOYSA-N 0.000 description 20
- 101100226895 Phomopsis amygdali PaP450-3 gene Proteins 0.000 description 20
- 101150083238 bsc7 gene Proteins 0.000 description 20
- 238000001976 enzyme digestion Methods 0.000 description 19
- 210000001938 protoplast Anatomy 0.000 description 19
- 238000004321 preservation Methods 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 17
- 101000870438 Streptococcus gordonii UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase stabilizing protein GtfB Proteins 0.000 description 17
- 241000187438 Streptomyces fradiae Species 0.000 description 17
- 101000645119 Vibrio campbellii (strain ATCC BAA-1116 / BB120) Nucleotide-binding protein VIBHAR_03667 Proteins 0.000 description 17
- 230000036961 partial effect Effects 0.000 description 17
- 108091008146 restriction endonucleases Proteins 0.000 description 17
- DIOQKPOBSJVSJS-UHFFFAOYSA-N 3,6-Dideoxy-3-dimethylamino-beta-D-glucose Natural products CC1OC(O)C(O)C(N(C)C)C1O DIOQKPOBSJVSJS-UHFFFAOYSA-N 0.000 description 16
- CEAGUSGLAUVBEQ-UHFFFAOYSA-N Forosamine Natural products CC1CC(N(C)C)CC(O)O1 CEAGUSGLAUVBEQ-UHFFFAOYSA-N 0.000 description 16
- IJUPCLYLISRDRA-UHFFFAOYSA-N Mycaminose Natural products CC(O)C(O)C(N(C)C)C(O)C=O IJUPCLYLISRDRA-UHFFFAOYSA-N 0.000 description 16
- 238000010367 cloning Methods 0.000 description 16
- SZGAAHDUAFVZSS-SFYZADRCSA-N forosamine Chemical compound C[C@@H](O)[C@@H](N(C)C)CCC=O SZGAAHDUAFVZSS-SFYZADRCSA-N 0.000 description 16
- IJUPCLYLISRDRA-ULAWRXDQSA-N mycaminose Chemical compound C[C@@H](O)[C@@H](O)[C@H](N(C)C)[C@@H](O)C=O IJUPCLYLISRDRA-ULAWRXDQSA-N 0.000 description 16
- 229930188070 thiostrepton Natural products 0.000 description 16
- 230000009466 transformation Effects 0.000 description 16
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 15
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 15
- 238000012216 screening Methods 0.000 description 15
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 15
- 229940063214 thiostrepton Drugs 0.000 description 15
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 15
- 241000191938 Micrococcus luteus Species 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 230000006798 recombination Effects 0.000 description 13
- 238000005215 recombination Methods 0.000 description 13
- 230000008521 reorganization Effects 0.000 description 13
- 238000001228 spectrum Methods 0.000 description 13
- 238000012056 up-stream process Methods 0.000 description 13
- 102000051366 Glycosyltransferases Human genes 0.000 description 12
- 108700023372 Glycosyltransferases Proteins 0.000 description 12
- 229930194936 Tylosin Natural products 0.000 description 12
- 239000004182 Tylosin Substances 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 235000019375 tylosin Nutrition 0.000 description 12
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 12
- 229960004059 tylosin Drugs 0.000 description 12
- 238000011144 upstream manufacturing Methods 0.000 description 12
- 101150009852 ORF2 gene Proteins 0.000 description 11
- 229920002684 Sepharose Polymers 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 238000010276 construction Methods 0.000 description 11
- 150000002402 hexoses Chemical class 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- 238000013016 damping Methods 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 101150062334 int gene Proteins 0.000 description 10
- 238000002744 homologous recombination Methods 0.000 description 9
- 230000006801 homologous recombination Effects 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- 238000013519 translation Methods 0.000 description 9
- 230000014621 translational initiation Effects 0.000 description 9
- 102000004316 Oxidoreductases Human genes 0.000 description 8
- 108090000854 Oxidoreductases Proteins 0.000 description 8
- 101100226897 Phomopsis amygdali PaAT-1 gene Proteins 0.000 description 8
- 101100220583 Rhizobium meliloti (strain 1021) cheD gene Proteins 0.000 description 8
- 241000187432 Streptomyces coelicolor Species 0.000 description 8
- 238000003208 gene overexpression Methods 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 231100000241 scar Toxicity 0.000 description 8
- 230000001131 transforming effect Effects 0.000 description 8
- 101100340330 Escherichia coli (strain K12) idlP gene Proteins 0.000 description 7
- 241000726221 Gemma Species 0.000 description 7
- 101100445522 Saccharopolyspora erythraea (strain ATCC 11635 / DSM 40517 / JCM 4748 / NBRC 13426 / NCIMB 8594 / NRRL 2338) ermE gene Proteins 0.000 description 7
- 125000003275 alpha amino acid group Chemical group 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 239000012228 culture supernatant Substances 0.000 description 7
- 230000009977 dual effect Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 102000002735 Acyl-CoA Dehydrogenase Human genes 0.000 description 6
- 108010001058 Acyl-CoA Dehydrogenase Proteins 0.000 description 6
- 108010030975 Polyketide Synthases Proteins 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000012239 gene modification Methods 0.000 description 6
- 230000005017 genetic modification Effects 0.000 description 6
- 235000013617 genetically modified food Nutrition 0.000 description 6
- 125000003147 glycosyl group Chemical group 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 229930001119 polyketide Natural products 0.000 description 6
- 150000003881 polyketide derivatives Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 101100071285 Escherichia phage T5 C1 gene Proteins 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 5
- VWVDRJWACDDRKD-SECFAUQFSA-N Platenolide A Chemical compound CC[C@H]1C[C@@H](C)C(=O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](O)[C@H](OC)[C@H]1O VWVDRJWACDDRKD-SECFAUQFSA-N 0.000 description 5
- 108700022994 Streptomyces fradiae tylB Proteins 0.000 description 5
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 108090000340 Transaminases Proteins 0.000 description 5
- 102000003929 Transaminases Human genes 0.000 description 5
- 108091035715 XIST (gene) Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 238000007069 methylation reaction Methods 0.000 description 5
- 101150111388 pac gene Proteins 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 101150066142 tsr gene Proteins 0.000 description 5
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 108091033380 Coding strand Proteins 0.000 description 4
- 241000701022 Cytomegalovirus Species 0.000 description 4
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 4
- 101000941045 Homo sapiens Cortactin-binding protein 2 Proteins 0.000 description 4
- 108090000604 Hydrolases Proteins 0.000 description 4
- 102000004157 Hydrolases Human genes 0.000 description 4
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 4
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 101100224737 Photorhabdus luminescens dtpB gene Proteins 0.000 description 4
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 4
- 101000936711 Streptococcus gordonii Accessory secretory protein Asp4 Proteins 0.000 description 4
- 210000004507 artificial chromosome Anatomy 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000004520 electroporation Methods 0.000 description 4
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 4
- 229940041033 macrolides Drugs 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000002906 microbiologic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000002741 site-directed mutagenesis Methods 0.000 description 4
- 238000005891 transamination reaction Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 102100020724 Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Human genes 0.000 description 3
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 description 3
- 101000820585 Homo sapiens SUN domain-containing ossification factor Proteins 0.000 description 3
- 101000673946 Homo sapiens Synaptotagmin-like protein 1 Proteins 0.000 description 3
- 108090001042 Hydro-Lyases Proteins 0.000 description 3
- 102000004867 Hydro-Lyases Human genes 0.000 description 3
- 102000004195 Isomerases Human genes 0.000 description 3
- 108090000769 Isomerases Proteins 0.000 description 3
- 101001110310 Lentilactobacillus kefiri NADP-dependent (R)-specific alcohol dehydrogenase Proteins 0.000 description 3
- 101000819644 Lysinibacillus sphaericus UPF0309 protein in nagA 3'region Proteins 0.000 description 3
- 102100021651 SUN domain-containing ossification factor Human genes 0.000 description 3
- 241000187560 Saccharopolyspora Species 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 101000901034 Streptococcus gordonii Accessory Sec system protein Asp2 Proteins 0.000 description 3
- 101000936720 Streptococcus gordonii Accessory secretory protein Asp5 Proteins 0.000 description 3
- 101000912941 Streptococcus gordonii DegV domain-containing protein Proteins 0.000 description 3
- 102000005488 Thioesterase Human genes 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- KFWWCMJSYSSPSK-PAXLJYGASA-N crotonoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)/C=C/C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 KFWWCMJSYSSPSK-PAXLJYGASA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- 101150114569 srmB gene Proteins 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- 108020002982 thioesterase Proteins 0.000 description 3
- 241001515965 unidentified phage Species 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108700016155 Acyl transferases Proteins 0.000 description 2
- 102000057234 Acyl transferases Human genes 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 101710134389 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001524679 Escherichia virus M13 Species 0.000 description 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 2
- 101000652805 Homo sapiens Protein shisa-8 Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- DMUAPQTXSSNEDD-QALJCMCCSA-N Midecamycin Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C DMUAPQTXSSNEDD-QALJCMCCSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 101150068419 ORF 1 gene Proteins 0.000 description 2
- 241000315040 Omura Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102100030890 Protein shisa-8 Human genes 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102100021588 Sterol carrier protein 2 Human genes 0.000 description 2
- 241000187392 Streptomyces griseus Species 0.000 description 2
- 101710175177 Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 2
- FQVHOULQCKDUCY-OGHXVOSASA-N [(2s,3s,4r,6s)-6-[(2r,3s,4r,5r,6s)-6-[[(1s,3r,7r,8s,9s,10r,12r,14e,16s)-7-acetyloxy-8-methoxy-3,12-dimethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimeth Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@H]1[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@@H]2O[C@H]2C[C@@H](C)OC(=O)C[C@H]([C@@H]1OC)OC(C)=O)[C@H]1C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1 FQVHOULQCKDUCY-OGHXVOSASA-N 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229940045799 anthracyclines and related substance Drugs 0.000 description 2
- 101150057950 aph gene Proteins 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000001217 buttock Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000002962 chemical mutagen Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000003209 gene knockout Methods 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 102000057593 human F8 Human genes 0.000 description 2
- 101150062015 hyg gene Proteins 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000006317 isomerization reaction Methods 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229960002757 midecamycin Drugs 0.000 description 2
- 239000006225 natural substrate Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920002704 polyhistidine Polymers 0.000 description 2
- 101150038504 pra gene Proteins 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229940047431 recombinate Drugs 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- PILBYTNNIUDJPF-UHFFFAOYSA-N 10-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Chemical compound C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)CC1OC1CC(N)C(O)C(C)O1 PILBYTNNIUDJPF-UHFFFAOYSA-N 0.000 description 1
- 101150106774 9 gene Proteins 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 241001281729 Aneurinibacillus thermoaerophilus Species 0.000 description 1
- 101100279048 Arabidopsis thaliana EDR4 gene Proteins 0.000 description 1
- 102000003916 Arrestin Human genes 0.000 description 1
- 108090000328 Arrestin Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 102000003849 Cytochrome P450 Human genes 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 230000003682 DNA packaging effect Effects 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108091022917 Gluconate dehydratase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000583581 Homo sapiens Polyhomeotic-like protein 3 Proteins 0.000 description 1
- 101000607335 Homo sapiens Serine/threonine-protein kinase ULK1 Proteins 0.000 description 1
- 108020005350 Initiator Codon Proteins 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- VKEQBMCRQDSRET-UHFFFAOYSA-N Methylone Chemical compound CNC(C)C(=O)C1=CC=C2OCOC2=C1 VKEQBMCRQDSRET-UHFFFAOYSA-N 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 101710134502 Mgp-operon protein 3 Proteins 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 101100540717 Mus musculus Washc1 gene Proteins 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 101150063292 ORF2a gene Proteins 0.000 description 1
- 101150000233 ORF4 gene Proteins 0.000 description 1
- 101710157860 Oxydoreductase Proteins 0.000 description 1
- 102100030905 Polyhomeotic-like protein 3 Human genes 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 102100039988 Serine/threonine-protein kinase ULK1 Human genes 0.000 description 1
- 108010052160 Site-specific recombinase Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000187178 Streptoalloteichus tenebrarius Species 0.000 description 1
- 241000187758 Streptomyces ambofaciens Species 0.000 description 1
- 101100371346 Streptomyces fradiae tylCV gene Proteins 0.000 description 1
- 101100371351 Streptomyces fradiae tylMII gene Proteins 0.000 description 1
- 101100371352 Streptomyces fradiae tylMIII gene Proteins 0.000 description 1
- 241001312733 Streptomyces griseofuscus Species 0.000 description 1
- 241000905500 Streptomyces hygroscopicus subsp. ascomyceticus Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 241001518258 Streptomyces pristinaespiralis Species 0.000 description 1
- 241000970863 Streptomyces rishiriensis Species 0.000 description 1
- 241000531819 Streptomyces venezuelae Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- UFUYRGNJTFAODM-UHFFFAOYSA-N Tylosin C Natural products O=CCC1CC(C)C(=O)C=CC(C)=CC(COC2C(C(O)C(O)C(C)O2)OC)C(CC)OC(=O)CC(O)C(C)C1OC(C(C1N(C)C)O)OC(C)C1OC1CC(C)(O)C(O)C(C)O1 UFUYRGNJTFAODM-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000006472 autoimmune response Effects 0.000 description 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- YSYKRGRSMLTJNL-URARBOGNSA-N dTDP-alpha-D-glucose Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](O)C1 YSYKRGRSMLTJNL-URARBOGNSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- HTRPPTAOBPKNBX-UHFFFAOYSA-N epsilon-Rhodomycinone Natural products CCC1(O)CC(O)c2c(O)c3C(=O)C4C(C=CC=C4O)C(=O)c3c(O)c2C1C(=O)OC HTRPPTAOBPKNBX-UHFFFAOYSA-N 0.000 description 1
- PYFOXRACBORDCT-GOSXWKPOSA-N epsilon-rhodomycinone Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1C(O)=C1[C@@H](O)C[C@@](CC)(O)[C@H](C(=O)OC)C1=C2O PYFOXRACBORDCT-GOSXWKPOSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- UFUYRGNJTFAODM-HQCAVAADSA-N macrocin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](O)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 UFUYRGNJTFAODM-HQCAVAADSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 101150013584 mdmB gene Proteins 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RZPAKFUAFGMUPI-QESOVKLGSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-QESOVKLGSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- WPMGNXPRKGXGBO-OFQQMTDKSA-N soraphen A Chemical compound C1([C@H]2OC(=O)[C@@H](C)[C@@]3(O)O[C@@H]([C@H](/C=C/[C@@H](OC)[C@@H](OC)CCCC2)C)[C@@H](C)[C@H](O)[C@H]3OC)=CC=CC=C1 WPMGNXPRKGXGBO-OFQQMTDKSA-N 0.000 description 1
- WPMGNXPRKGXGBO-UHFFFAOYSA-N soraphen A1alpha Natural products COC1C(O)C(C)C(C(C=CC(OC)C(OC)CCCC2)C)OC1(O)C(C)C(=O)OC2C1=CC=CC=C1 WPMGNXPRKGXGBO-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0212489A FR2845394A1 (fr) | 2002-10-08 | 2002-10-08 | Polypeptides impliques dans la biosynthese des spiramycines, sequences nucleotidiques codant ces polypeptides et leurs applications |
FR0212489 | 2002-10-08 | ||
FR0302439 | 2003-02-27 | ||
FR0302439A FR2851773A1 (fr) | 2003-02-27 | 2003-02-27 | Polypeptides impliques dans la biosynthese des spiramycines, sequences nucleotidiques codant ces polypeptides et leurs applications |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2003801029666A Division CN1711355A (zh) | 2002-10-08 | 2003-10-08 | 参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101302528A CN101302528A (zh) | 2008-11-12 |
CN101302528B true CN101302528B (zh) | 2012-05-30 |
Family
ID=32011514
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100823963A Expired - Lifetime CN101302528B (zh) | 2002-10-08 | 2003-10-08 | 参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 |
CNA2003801029666A Pending CN1711355A (zh) | 2002-10-08 | 2003-10-08 | 参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2003801029666A Pending CN1711355A (zh) | 2002-10-08 | 2003-10-08 | 参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 |
Country Status (3)
Country | Link |
---|---|
CN (2) | CN101302528B (fr) |
FR (1) | FR2845394A1 (fr) |
ZA (1) | ZA200502139B (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0791655A2 (fr) * | 1996-02-22 | 1997-08-27 | Eli Lilly And Company | Gènes de polyketide-synthase |
EP0791656A3 (fr) * | 1996-02-22 | 2000-10-18 | Eli Lilly And Company | Gène de la platenolide-synthase |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001511349A (ja) * | 1997-07-25 | 2001-08-14 | ヘキスト・マリオン・ルセル | Saccharopolysporaerythraea及びStreptomycesantibioticusにおける6−デオキシヘキソースの生合成及び移送のための遺伝子 |
-
2002
- 2002-10-08 FR FR0212489A patent/FR2845394A1/fr active Pending
-
2003
- 2003-10-08 CN CN2008100823963A patent/CN101302528B/zh not_active Expired - Lifetime
- 2003-10-08 CN CNA2003801029666A patent/CN1711355A/zh active Pending
-
2005
- 2005-03-14 ZA ZA200502139A patent/ZA200502139B/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0791655A2 (fr) * | 1996-02-22 | 1997-08-27 | Eli Lilly And Company | Gènes de polyketide-synthase |
EP0791656A3 (fr) * | 1996-02-22 | 2000-10-18 | Eli Lilly And Company | Gène de la platenolide-synthase |
Also Published As
Publication number | Publication date |
---|---|
ZA200502139B (en) | 2006-05-31 |
CN101302528A (zh) | 2008-11-12 |
FR2845394A1 (fr) | 2004-04-09 |
CN1711355A (zh) | 2005-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6200813B1 (en) | Polyketide derivatives and recombinant methods for making same | |
KR100588436B1 (ko) | 스피노신 살충제 제조용 생합성 유전자 | |
Metsä-Ketelä et al. | Partial activation of a silent angucycline-type gene cluster from a rubromycin β producing Streptomyces sp. PGA64 | |
Zhao et al. | Sequential improvement of rimocidin production in Streptomyces rimosus M527 by introduction of cumulative drug-resistance mutations | |
Salcedo et al. | Characterization and engineering of the biosynthesis gene cluster for antitumor macrolides PM100117 and PM100118 from a marine actinobacteria: generation of a novel improved derivative | |
US5786181A (en) | Process for producing high purity 6, 12-dideoxyerythromycin A by fermentation | |
US7795001B2 (en) | Midecamycin biosynthesis genes | |
Knirschova et al. | Multiple regulatory genes in the salinomycin biosynthetic gene cluster of Streptomyces albus CCM 4719 | |
CN101302528B (zh) | 参与螺旋霉素生物合成的多肽、编码这些多肽的核苷酸序列及其应用 | |
JP7086984B2 (ja) | Streptomyces fungicidicusの遺伝子組換え株におけるエンデュラシジンの産生を増強するための組成物及び方法 | |
JP5042497B2 (ja) | スピラマイシンの生合成に関与するポリペプチド、これらポリペプチドをコードするヌクレオチド配列、および、その使用 | |
Prasad et al. | Cloning and characterization of a gene cluster for the production of polyketide macrolide dihydrochalcomycin in Streptomyces sp. KCTC 0041BP | |
US7579167B2 (en) | Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof | |
Boakes et al. | A new modular polyketide synthase in the erythromycin producer Saccharopolyspora erythraea | |
EP1905833B1 (fr) | Polypeptides impliqués dans la biosynthèse des spiramycines, séquences nucléotidiques codant ces polypeptides et leurs applications | |
US20040219645A1 (en) | Polyketides and their synthesis | |
Novakova et al. | Cloning and characterization of a new polyketide synthase gene cluster in Streptomyces aureofaciens CCM 3239 | |
Arakawa | Characterization of the Biosynthetic Gene Clusters Located on the Streptomyces Linear Plasmid | |
FR2851773A1 (fr) | Polypeptides impliques dans la biosynthese des spiramycines, sequences nucleotidiques codant ces polypeptides et leurs applications | |
Park et al. | Cloning of relA from Actinoplanes teichomyceticus ATCC31121 and its application for increases in antibiotic production | |
Fiedler et al. | Biosynthetic Gene Cluster of | |
Kim et al. | Cloning of relA from Actinoplanes teichomyceticus ATCC31121 and Its Application Seung-Yong Park | |
Nezbedová | Secondary metabolism and its regulation in Streptomyces ambofaciens: the study of cryptic secondary metabolite biosynthetic gene clusters | |
CA2241139A1 (fr) | Genes de biosynthese de sucres associes a des polyketides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1122330 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1122330 Country of ref document: HK |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20120530 |